Dr. Jonathan Silk, PhD
Senior Director Integrated Drug Discovery CAR-T & Other CGT, Vaccine, Cellular Assay, In Vivo Pharmacology, Animal Model, Oncology, Immunology, Autoimmune Disease, Infectious Disease, Inflammatory Disease, Other Target Classes, Multispecific Antibodies, Monoclonal Antibodies, Biochemical Assay
Dr. Jonathan (Jon) Silk, an expert in immunology, immunotherapy, and translational drug discovery, joined WuXi Biology in 2026 as Senior Director of Integrated Drug Discovery. Jonathan has a broad technical background, including immunology, immuno-oncology, T-cell and TCR biology, translational science, target discovery, and in vivo and in vitro assay development. Previous leadership positions include Director of Biology at Enara Bio and Head of Next Gen Research at Adaptimmune, where he led discovery and translational programs from concept through candidate selection and the IND-enabling stage. Jonathan holds a PhD in Immunology (Transplantation) from Imperial College London and a BSc in Biochemistry with a year in industry from the University of Kent. He ran his own scientific consultancy advising Biotechs, CROs, and investors, and has published widely in immunology by authoring numerous papers, patents, and book chapters.